Pravin U. Dugel, MD, Managing Partner of Retinal Consultants of Arizona in Phoenix, Clinical Associate Professor of Ophthalmology at the University of Southern California Doheny Eye Institute Keck School of Medicine in Los Angeles, and Founding Member of the Spectra Eye Institute in Sun City, AZ, reviews the phase 3 clinical trial results on ocriplasmin for symptomatic vitreomacular adhesion.

1,346 video views and 24,238 series views since

  • Bookmark
  • QuickLink